EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Expanding the Gene Expression Profiling of Drug Transporters and Drug-Metabolizing Enzymes to Include the Upper Female Reproductive Tract

An Le iD, Guru R Valicherla iD, Junmei Zhang iD, Lin Wang iD, Mark K Donnelly iD, Robert Bies iD, Lisa C Rohan iD

Pharmaceutics · 21.05.2026 · 18 (5) · 629

DOI: 10.3390/pharmaceutics18050629 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 21.05.2026. Verfasst von An Le und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA 15213, USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gates Foundation, United States Food and Drug Administration, FDA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: With the ongoing efforts in supporting the discovery of novel targeted drug delivery systems for the upper region of the female reproductive tract (FRT), it is imperative to understand the local drug disposition pathways. We aim to obtain a comprehensive profile of the drug transporters and drug-metabolizing enzymes in the human ectocervix, uterus, and fallopian tubes, as these factors may substantially influence mucosal penetration, tissue exposure, drug disposition, and the risk of drug–drug interactions.

Methods

Gene expression of 12 drug transporters and 21 drug-metabolizing enzymes was quantified using RT-qPCR. Protein expression of highly expressed transporters was assessed using immunohistochemistry (IHC).

Results

Among the 12 transporters analyzed, the efflux transporters P-gp, BCRP, and MRP4 exhibited the highest expression across the ectocervix, endometrium, myometrium, and fallopian tubes, with P-gp consistently showing the greatest abundance in all evaluated FRT tissues. Expression of these transporters was significantly higher (6–17×) in myometrium compared with ectocervix. IHC demonstrated strong localization of P-gp, BCRP, and MRP4 to epithelial layers facing the lumen, as well as to stromal and vascular endothelial cells. For drug-metabolizing enzymes, all 21 phase I and II enzymes were detectable across the FRT, and 15 were expressed at comparatively higher levels across all tissue types. These included CYP1A1, CYP1B1, CYP2B6, CYP2C8, CYP2C19, CYP3A4, UGT1A1, UGT1A3, UGT1A4, UGT1A7, UGT1A8, UGT1A10, UGT2B4, UGT2B15, and UGT2B17.

Conclusions

The gene expression and localization data obtained from this work may improve our understanding of drug disposition in the FRT, which will inform selection, design, and optimization of drugs intended for targeted delivery within the FRT.

Schlagwörter

Stichwörter der Autor:innen

drug transportersdrug-metabolizing enzymesfemale reproductive tractgene expressionimmunohistochemistry

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA 15213, USA.
  • Magee-Womens Research Institute, Pittsburgh, PA 15213, USA.
  • Department of Obstetrics, Gynecology, and Reproductive Sciences, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15213, USA.
  • Division of Quantitative Methods and Modeling (DQMM), Office of Research and Standards (ORS), Office of Generic Drugs (OGD), Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Silve…
  • Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, NY 14214, USA.

ORCID-Profile: An Le, Guru R Valicherla, Junmei Zhang, Lin Wang, Mark K Donnelly, Robert Bies, Lisa C Rohan

Förderung

  • Gates Foundation
  • United States Food and Drug Administration
  • FDA

Zitieren

APA

Le, A., Valicherla, G. R., Zhang, J., Wang, L., Donnelly, M. K., Bies, R., & Rohan, L. C. (2026). Expanding the Gene Expression Profiling of Drug Transporters and Drug-Metabolizing Enzymes to Include the Upper Female Reproductive Tract. Pharmaceutics, 18(5), 629. https://doi.org/10.3390/pharmaceutics18050629

Vancouver

Le A, Valicherla GR, Zhang J, Wang L, Donnelly MK, Bies R, et al. Expanding the Gene Expression Profiling of Drug Transporters and Drug-Metabolizing Enzymes to Include the Upper Female Reproductive Tract. Pharmaceutics. 2026;18(5):629. doi:10.3390/pharmaceutics18050629

BibTeX
@article{Le2026,
  author = {Le, An and Valicherla, Guru R and Zhang, Junmei and Wang, Lin and Donnelly, Mark K and Bies, Robert and Rohan, Lisa C},
  title = {Expanding the Gene Expression Profiling of Drug Transporters and Drug-Metabolizing Enzymes to Include the Upper Female Reproductive Tract},
  journal = {Pharmaceutics},
  year = {2026},
  volume = {18},
  number = {5},
  pages = {629},
  doi = {10.3390/pharmaceutics18050629}
}
Kostenlos starten →